Literature DB >> 11226706

Calcium channels coupled to neurotransmitter release at dually innervated neuromuscular junctions in the newborn rat.

M M Santafé1, N Garcia, M A Lanuza, O D Uchitel, J Tomás.   

Abstract

We studied the effect of several calcium channel blockers (omega-Conotoxin-GVIA, 1 and 3microM; omega-Agatoxin-IVA, 100nM; Nitrendipine, 1 and 10microM) on evoked transmitter release at singly and dually innervated endplates of the levator auris longus muscle from three- to six-day-old rats. In dually innervated fibers, a second endplate potential may appear after the first one when we increase the stimulation intensity. The lowest and highest endplate potential amplitudes are designated "small endplate potential" and "large endplate potential", respectively. The percentage of doubly innervated junctions remains almost constant throughout the age range examined. Nevertheless, the percentage of junctions innervated by three or more terminal axons drops, whereas the singly innervated junctions increase. Therefore, between postnatal days 3 and 6, roughly half the neuromuscular junctions may experience the final process of axonal elimination. The synaptic efficacy of the large endplate potential in dual junctions, measured as the mean amplitude of the synaptic potential and mean quantal content, was the same as in the junctions that had become recently mono-innervated in the same postnatal period. In singly innervated fibers, the endplate potential size was strongly reduced by both the P/Q-type voltage-dependent calcium channel blocker omega-Agatoxin-IVA (79.17+/-4.02%; P < 0.05) and the N-type voltage-dependent calcium channel blocker omega-Conotoxin-GVIA (56.31+/-7.80%; P < 0.05), whereas endplate potential amplitude was not significantly changed by the L-type voltage-dependent calcium channel blocker Nitrendipine. In dually innervated fibers, the P/Q-type voltage-dependent calcium channel blocker omega-Agatoxin-IVA and L-type voltage-dependent calcium channel blocker Nitrendipine increased the size of the small endplate potential (161.29+/-47.87% and 109.32+/-11.03%, respectively; P < 0.05 in both cases) and reduced the large endplate potential (74.42+/-15.32% and 70.91+/-10.04%, respectively; P < 0.05 in both cases). The N-type voltage-dependent calcium channel blocker omega-Conotoxin-GVIA significantly increased the small endplate potential in the first few minutes after toxin application (at 10min: 90.23+/-17.38%; P < 0.05). This increase was not maintained, while the large endplate potential was strongly inhibited (69.25+/-7.5%; P < 0.05). In conclusion, in the dually innervated endplates of the newborn rat, presynaptic calcium channel types can have different roles in transmitter release from each of the two inputs, which suggests that nerve terminal voltage-dependent calcium channels are involved in neonatal synaptic maturation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11226706     DOI: 10.1016/s0306-4522(00)00507-8

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  19 in total

Review 1.  Protein kinase C isoforms at the neuromuscular junction: localization and specific roles in neurotransmission and development.

Authors:  Maria A Lanuza; Manel M Santafe; Neus Garcia; Núria Besalduch; Marta Tomàs; Teresa Obis; Mercedes Priego; Phillip G Nelson; Josep Tomàs
Journal:  J Anat       Date:  2013-09-15       Impact factor: 2.610

2.  Classical 18.5-and 21.5-kDa isoforms of myelin basic protein inhibit calcium influx into oligodendroglial cells, in contrast to golli isoforms.

Authors:  Graham S T Smith; Pablo M Paez; Vilma Spreuer; Celia W Campagnoni; Joan M Boggs; Anthony T Campagnoni; George Harauz
Journal:  J Neurosci Res       Date:  2011-01-13       Impact factor: 4.164

3.  Loss of β2-laminin alters calcium sensitivity and voltage-gated calcium channel maturation of neurotransmission at the neuromuscular junction.

Authors:  Kirat K Chand; Kah Meng Lee; Mitja P Schenning; Nickolas A Lavidis; Peter G Noakes
Journal:  J Physiol       Date:  2014-12-01       Impact factor: 5.182

4.  Involvement of dihydropyridine-sensitive calcium channels in high asynchrony of transmitter release in neuromuscular synapses of newborn rats.

Authors:  V F Khuzakhmetova; L F Nurullin; E A Bukharaeva; E E Nikolsky
Journal:  Dokl Biol Sci       Date:  2016-11-08

5.  Calcium channel subtypes contributing to acetylcholine release from normal, 4-aminopyridine-treated and myasthenic syndrome auto-antibodies-affected neuromuscular junctions.

Authors:  F Giovannini; E Sher; R Webster; J Boot; B Lang
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

6.  Altered intracellular Ca2+ homeostasis in nerve terminals of severe spinal muscular atrophy mice.

Authors:  Rocío Ruiz; Juan José Casañas; Laura Torres-Benito; Raquel Cano; Lucía Tabares
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

7.  Passive transfer of Lambert-Eaton syndrome to mice induces dihydropyridine sensitivity of neuromuscular transmission.

Authors:  Michael T Flink; William D Atchison
Journal:  J Physiol       Date:  2002-09-01       Impact factor: 5.182

Review 8.  Ca2+ channels as targets of neurological disease: Lambert-Eaton Syndrome and other Ca2+ channelopathies.

Authors:  Michael T Flink; William D Atchison
Journal:  J Bioenerg Biomembr       Date:  2003-12       Impact factor: 2.945

9.  Tetanic depression is overcome by tonic adenosine A(2A) receptor facilitation of L-type Ca(2+) influx into rat motor nerve terminals.

Authors:  Laura Oliveira; M Alexandrina Timóteo; Paulo Correia-de-Sá
Journal:  J Physiol       Date:  2004-08-05       Impact factor: 5.182

10.  The novel protein kinase C epsilon isoform at the adult neuromuscular synapse: location, regulation by synaptic activity-dependent muscle contraction through TrkB signaling and coupling to ACh release.

Authors:  Teresa Obis; Núria Besalduch; Erica Hurtado; Laura Nadal; Manel M Santafe; Neus Garcia; Marta Tomàs; Mercedes Priego; Maria A Lanuza; Josep Tomàs
Journal:  Mol Brain       Date:  2015-02-10       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.